Randomized Trial of Intensive Motivational Interviewing for Methamphetamine Dependence

Overview

Journal J Addict Dis

Publisher Informa Healthcare

Date 2014 Aug 14

PMID 25115166

Citations 21

Authors

Douglas L Polcin

Jason Bond

Rachael Korcha

Madhabika B Nayak

Gantt P Galloway

Kristy Evans

Affiliations

Soon will be listed here.

Abstract

An intensive, 9-session motivational interviewing (IMI) intervention was assessed using a randomized clinical trial of 217 methamphetamine (MA) dependent individuals. Intensive motivational interviewing (IMI) was compared with a single standard session of MI (SMI) combined with eight nutrition education sessions. Interventions were delivered weekly over 2 months. All study participants also received standard outpatient group treatment three times per week. Both study groups showed significant decreases in MA use and Addiction Severity Index drug scores, but there were no significant differences between the two groups. However, reductions in Addiction Severity Index psychiatric severity scores and days of psychiatric problems during the past 30 days were found for clients in the IMI group but not the SMI group. SMI may be equally beneficial to IMI in reducing MA use and problem severity, but IMI may help alleviate co-occurring psychiatric problems that are unaffected by shorter MI interventions. Additional studies are needed to assess the problems, populations, and contexts for which IMI is effective.

Citing Articles

Psychosocial interventions for stimulant use disorder.

Minozzi S, Saulle R, Amato L, Traccis F, Agabio R Cochrane Database Syst Rev. 2024; 2:CD011866.

PMID: 38357958 PMC: 10867898. DOI: 10.1002/14651858.CD011866.pub3.

Psychosocial and pharmacologic interventions for problematic methamphetamine use: Findings from a scoping review of the literature.

Hersi M, Corace K, Hamel C, Esmaeilisaraji L, Rice D, Dryburgh N PLoS One. 2023; 18(10):e0292745.

PMID: 37819931 PMC: 10566716. DOI: 10.1371/journal.pone.0292745.

Identification of Potential Biomarkers for Diagnosis of Patients with Methamphetamine Use Disorder.

Jang W, Song S, Son T, Bae J, Lee S, Jeong C Int J Mol Sci. 2023; 24(10).

PMID: 37240016 PMC: 10218193. DOI: 10.3390/ijms24108672.

Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail.

Hazani H, Naina Mohamed I, Muzaimi M, Mohamed W, Yahaya M, Teoh S Front Pharmacol. 2022; 13:859563.

PMID: 35462918 PMC: 9021401. DOI: 10.3389/fphar.2022.859563.

An adaptive design to screen, treat, and retain people with opioid use disorders who use methamphetamine in methadone clinics (STAR-OM): study protocol of a clinical trial.

Giang L, Trang N, Diep N, Thuy D, Thuy D, Hoe H Trials. 2022; 23(1):342.

PMID: 35461300 PMC: 9034071. DOI: 10.1186/s13063-022-06278-w.

References

McLellan A, Luborsky L, Woody G, OBrien C . An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980; 168(1):26-33. DOI: 10.1097/00005053-198001000-00006. View

Cacciola J, Alterman A, McLellan A, Lin Y, Lynch K . Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index. Drug Alcohol Depend. 2006; 87(2-3):297-302. DOI: 10.1016/j.drugalcdep.2006.09.002. View

Mullins S, Suarez M, Ondersma S, Page M . The impact of motivational interviewing on substance abuse treatment retention: a randomized control trial of women involved with child welfare. J Subst Abuse Treat. 2004; 27(1):51-8. DOI: 10.1016/j.jsat.2004.03.010. View

Bien T, Miller W, Tonigan J . Brief interventions for alcohol problems: a review. Addiction. 1993; 88(3):315-35. DOI: 10.1111/j.1360-0443.1993.tb00820.x. View

Korcha R, Polcin D, Evans K, Bond J, Galloway G . Intensive motivational interviewing for women with concurrent alcohol problems and methamphetamine dependence. J Subst Abuse Treat. 2013; 46(2):113-9. PMC: 3840101. DOI: 10.1016/j.jsat.2013.08.013. View

Clifford P, Maisto S, Davis C . Alcohol treatment research assessment exposure subject reactivity effects: part I. Alcohol use and related consequences. J Stud Alcohol Drugs. 2007; 68(4):519-28. DOI: 10.15288/jsad.2007.68.519. View

Seligman M . The effectiveness of psychotherapy. The Consumer Reports study. Am Psychol. 1995; 50(12):965-74. DOI: 10.1037//0003-066x.50.12.965. View

Donovan D, Rosengren D, Downey L, Cox G, Sloan K . Attrition prevention with individuals awaiting publicly funded drug treatment. Addiction. 2001; 96(8):1149-60. DOI: 10.1046/j.1360-0443.2001.96811498.x. View

Lundahl B, Burke B . The effectiveness and applicability of motivational interviewing: a practice-friendly review of four meta-analyses. J Clin Psychol. 2009; 65(11):1232-45. DOI: 10.1002/jclp.20638. View

10.

Kelly T, Daley D, Douaihy A . Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav. 2011; 37(1):11-24. PMC: 3196788. DOI: 10.1016/j.addbeh.2011.09.010. View

11.

Polcin D, Buscemi R, Nayak M, Korcha R, Galloway G . Gender Differences in Psychiatric Symptoms among Methamphetamine Dependent Residents in Sober Living Houses. Addict Disord Their Treat. 2013; 11(2):53-63. PMC: 3614000. DOI: 10.1097/ADT.0b013e3182213ef1. View

12.

Burke B, Arkowitz H, Menchola M . The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003; 71(5):843-61. DOI: 10.1037/0022-006X.71.5.843. View

13.

Glasner-Edwards S, Mooney L, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R . Psychopathology in methamphetamine-dependent adults 3 years after treatment. Drug Alcohol Rev. 2010; 29(1):12-20. PMC: 3772133. DOI: 10.1111/j.1465-3362.2009.00081.x. View

14.

Hettema J, Steele J, Miller W . Motivational interviewing. Annu Rev Clin Psychol. 2007; 1:91-111. DOI: 10.1146/annurev.clinpsy.1.102803.143833. View

15.

Galloway G, Polcin D, Kielstein A, Brown M, Mendelson J . A nine session manual of motivational enhancement therapy for methamphetamine dependence: adherence and efficacy. J Psychoactive Drugs. 2008; Suppl 4:393-400. DOI: 10.1080/02791072.2007.10399900. View

16.

. Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol. 1997; 58(1):7-29. View

17.

Sellman J, Sullivan P, Dore G, Adamson S, MacEwan I . A randomized controlled trial of motivational enhancement therapy (MET) for mild to moderate alcohol dependence. J Stud Alcohol. 2001; 62(3):389-96. DOI: 10.15288/jsa.2001.62.389. View

18.

Carroll K, Ball S, Nich C, Martino S, Frankforter T, Farentinos C . Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend. 2005; 81(3):301-12. PMC: 2386852. DOI: 10.1016/j.drugalcdep.2005.08.002. View

19.

Winhusen T, Kropp F, Babcock D, Hague D, Erickson S, Renz C . Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users. J Subst Abuse Treat. 2007; 35(2):161-73. PMC: 2546520. DOI: 10.1016/j.jsat.2007.09.006. View

20.

Dunn C, Deroo L, Rivara F . The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction. 2002; 96(12):1725-42. DOI: 10.1046/j.1360-0443.2001.961217253.x. View